{
    "organizations": [],
    "uuid": "fd00961fec426d246979291f42498fe896693305",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-gemphire-therapeutics-names-steven/brief-gemphire-therapeutics-names-steven-gullans-ceo-idUSASC09ZN3",
    "ord_in_thread": 0,
    "title": "Gemphire Therapeutics Names Steven Gullans CEO",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 3 (Reuters) - Gemphire Therapeutics Inc:\n* GEMPHIRE THERAPEUTICS ANNOUNCES THE APPOINTMENT OF STEVEN GULLANS, PH.D., AS PRESIDENT AND CHIEF EXECUTIVE OFFICER\n* GEMPHIRE THERAPEUTICS INC - GULLANS HAS BEEN INTERIM PRESIDENT AND CHIEF EXECUTIVE OFFICER SINCE MAY 2017 Source text for Eikon:\nOur ",
    "published": "2018-05-04T04:22:00.000+03:00",
    "crawled": "2018-05-04T16:45:09.006+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "gemphire",
        "therapeutic",
        "inc",
        "gemphire",
        "therapeutic",
        "announces",
        "appointment",
        "steven",
        "gullans",
        "president",
        "chief",
        "executive",
        "officer",
        "gemphire",
        "therapeutic",
        "inc",
        "gullans",
        "interim",
        "president",
        "chief",
        "executive",
        "officer",
        "since",
        "may",
        "source",
        "text",
        "eikon"
    ]
}